Evidence map›Paper›PMID 32019241›Full record

ArticleInternational journal of molecular sciences2020

Phenylthiourea Binding to Human Tyrosinase-Related Protein 1.

Xuelei Lai, Harry J Wichers, Montserrat Soler-Lopez, Bauke W Dijkstra

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Discovery of Tyrosinase Inhibitors fromCurrent issues in molecular biology · 2026
    Article
  3. Article
  4. Article
  5. Recent Advances and Progress on Melanin: From Source to Application.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Medicinal Effect,Scientifica · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Xuelei LaiLaboratory of Biophysical Chemistry, University of Groningen, 9717 GA Groningen, The Netherlands.
Harry J WichersWageningen University & Research, 6708 WG Wageningen, The Netherlands.
Montserrat Soler-LopezEuropean Synchrotron Radiation Facility, 38043 Grenoble, France.
Bauke W DijkstraLaboratory of Biophysical Chemistry, University of Groningen, 9717 GA Groningen, The Netherlands.
University of Groningen · NLEuropean Synchrotron Radiation Facility · FRWageningen University & Research · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tyrosinase-related protein 1 (TYRP1) is one of the three human melanogenic enzymes involved in the biosynthesis of melanin, a pigment responsible for the color of the skin, hair, and eyes. It shares high sequence identity with tyrosinase, but has two zinc ions in its active site rather than two copper ions as in tyrosinase. Typical tyrosinase inhibitors do not directly coordinate to the zinc ions of TYRP1. Here, we show, from an X-ray crystal structure determination, that phenylthiourea, a highly potent tyrosinase inhibitor, does neither coordinate the active site zinc ions, but binds differently from other structurally characterized TYRP1-inhibitor complexes. Its aromatic ring is directed outwards from the active site, apparently as a result from the absence of polar oxygen substituents that can take the position of water molecules bound in the active site. The compound binds via hydrophobic interactions, thereby blocking substrate access to the active site.

Indexed as

Catalytic DomainCrystallography, X-RayHumansMembrane GlycoproteinsModels, MolecularOxidoreductasesPhenylthioureaProtein ConformationMembrane GlycoproteinsOxidoreductasesPhenylthioureaTYRP1 protein, humanalbinismcrystal structurehuman tyrosinasehuman tyrosinase-related proteininhibitormelanogenesisN-glycosylationphenylthioureazinc–copper enzymes

Identifiers

PMID32019241
PMCPMC7036772
OpenAlexW3003391415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.